Interestingly, studies had reported that miR-99a is induced to be down-regulated when c-Src is activated, and re-overexpressed miR-99a can target mTOR/FGFR3 to inhibit Src-related oncogenic pathways and thereby inhibit the growth of lung cancer cells (36). The gene discussed is FGFR3; the disease is lung carcinoma.